US Patent 11311521 Solid dispersion forms of rifaximin
Patent 11311521 was granted and assigned to Salix Pharmaceuticals on April, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Mohammed A. Kabir0
Pam Golden0
Edits on 31 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
113115210
Date of Patent
April 26, 2022
0Patent Application Number
174684570
Date Filed
September 7, 2021
0Patent Citations
Patent Primary Examiner
CPC Code
Golden AI
Infobox
Patent Citations
Edits on 19 May, 2022
Golden AI
Edits made to:
Infobox (+13 properties)
Article (+108 characters)
US Patent 11311521 Solid dispersion forms of rifaximin
Article
Provided herein are solid dispersions comprising rifaximin and pharmaceutical compositions and uses thereof.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11311521
Date of patent
April 26, 2022
Patent application number
17468457
Date Filed
September 7, 2021
Patent citations
Patent primary examiner
CPC Code
Find more entities like US Patent 11311521 Solid dispersion forms of rifaximin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
